Exploration of medical cannabinoid-therapies in Germany - an anonymous survey
- Conditions
- Any condition that is currently being treated with prescribed cannabinoids.
- Registration Number
- DRKS00023344
- Lead Sponsor
- Charité-Hochschulambulanz für Naturheilkunde im Immanuel-Krankenhaus Berlin-Wannsee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 211
Inclusion Criteria
Ongoing therapy with prescription-cannabinoids or prescription-cannabinoid-therapy within the last year.
-Internet access.
-Kognitive ability to participate in a 45-min survey online.
-Informed consent.
Exclusion Criteria
Non-consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This is an exploratory study. It does not have one single primary endpoint.<br>Variables include:<br><br>• Demography (age, occupation, marital status, training, income)<br>• Treatment Satisfaction Questionnaire for Medication (TSQM-II) <br>• Wellbeing (WHO-5)<br>• Patient Reported Outcomes Measurement Information System (PROMIS-29)<br>• Short screening-scale for post traumatic stress disorder DSM-IV<br>• Brief Pain Inventory (BPI)<br>• Face Pain Scale (FPS-R)<br>• Numeric Rating Scale pain (NRS)<br>• MS Spasticity Scale-88 (MSSS-88)<br>• Anorexia Nervosa Inventory (ANIS)<br>• Minimal Documentations-System (MIDOS)<br>• Hospital Anxiety and Depression Scale (HADS) <br>• Adult ADHD Self-Report Scale (ASRS-v1.1)<br>• Substance abuse (alcohol, nicotine, etc.)
- Secondary Outcome Measures
Name Time Method